Notably, none of the more than 150 liposarcoma samples of any type (i.e., atypical lipomatous tumor, dedifferentiated, myxoid and pleomorphic liposarcoma) showed MET amplification, MET copy number gain or MET or HGF overexpression. This evidence concerns the gene MET and liposarcoma.